Approval · Notice of Compliance 2209 · 2001
20% PROSOL: Notice of Compliance 2209
Issued October 30, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2209
- Date
- October 30, 2001
- Company
- Baxter Corporation Clintec Nutrition DivisionMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Product name change from 20% travasol
- Therapeutic class
- Nutritive supplement
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| 20% PROSOL | 02141450 | Marketed |
Medicinal ingredients
- ALANINE 2.76 G per 100ML
- ARGININE 1.96 G per 100ML
- L-ASPARTIC ACID 0.6 G per 100ML
- GLUTAMIC ACID 1.02 G per 100ML
- GLYCINE 2.06 G per 100ML
- HISTIDINE 1.18 G per 100ML
- ISOLEUCINE 1.08 G per 100ML
- LYSINE ACETATE 1.35 G per 100ML
- LEUCINE 1.08 G per 100ML
- DL-METHIONINE 0.76 G per 100ML
- PHENYLALANINE 1 G per 100ML
- PROLINE 1.34 G per 100ML
- SERINE 1.02 G per 100ML
- THREONINE 0.98 G per 100ML
- TRYPTOPHAN 0.32 G per 100ML
- TYROSINE 0.05 G per 100ML
- VALINE 1.44 G per 100ML